Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Anastasia‐Maria Zavitsanou, Ray Pillai, Hao Yuan, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113295-113295
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

The pleiotropic functions of reactive oxygen species in cancer
Katherine Wu, Ahmed E. El Zowalaty, Volkan I. Sayin, et al.
Nature Cancer (2024) Vol. 5, Iss. 3, pp. 384-399
Closed Access | Times Cited: 55
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer
Ray Pillai, Sarah E. LeBoeuf, Yuan Hao, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 19
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 8
Thirty years of NRF2: advances and therapeutic challenges
Donna D. Zhang
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC
Biagio Ricciuti, Marina Chiara Garassino
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 6, pp. 877-882
Closed Access | Times Cited: 6
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 6
NRF2 signaling pathway in chemo/radio/immuno-therapy resistance of lung cancer: Looking beyond the tip of the iceberg
Sri Vidya Ramisetti, Tapas Patra, Vinayak Munirathnam, et al.
Archivos de Bronconeumología (2024) Vol. 60, pp. S59-S66
Closed Access | Times Cited: 5
NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma
Samera H. Hamad, Rani S. Sellers, Nathan Wamsley, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 487-495
Open Access | Times Cited: 4
Tumor suppressor genotype influences the extent and mode of immunosurveillance in lung cancer
Keren M. Adler, Haiqing Xu, Amy C. Gladstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Construction of a lung adenocarcinoma prognostic model based on KEAP1/NRF2/HO‑1 mutation‑mediated upregulated genes and bioinformatic analysis
Wei Zhu, Zhang Ye, Lingyun Yang, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access
TNFAIP2 promotes NF-κB signaling mediate lymph node metastasis of oral squamous cell carcinoma by protecting IKKβ from ubiquitin proteasome degradation
Xu Teng, Yaning Wang, Zechen Zhao, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Cooperative nutrient scavenging is an evolutionary advantage in cancer
Gizem Guzelsoy, Setiembre D. Elorza, Manon Ros, et al.
Nature (2025)
Open Access
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
Pedro Rocha, Rafael Bach, Laura Masfarré, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Integration of multiple machine learning approaches develops a gene mutation-based classifier for accurate immunotherapy outcomes
Run Shi, Jing Sun, Zhaokai Zhou, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Integrative analysis of a novel signature incorporating metabolism and stemness-related genes for risk stratification and assessing clinical outcomes and therapeutic responses in lung adenocarcinoma
Wanrong Zheng, Chuchu Zhou, Zhiyi Xue, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
A human model to deconvolve genotype-phenotype causations in lung squamous cell carcinoma
Julia Ogden, Robert M. Sellers, Sudhakar Sahoo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Douglas B. Fox, Richard Y. Ebright, Xin Hong, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors
Dimitris Karagiannis, Warren Wu, Albert P. Li, et al.
Cell Reports (2023) Vol. 43, Iss. 1, pp. 113629-113629
Open Access | Times Cited: 8
Mutant Nrf2E79Q enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors
John G. Witherspoon, Jonathan R. Hall, Dereje D. Jima, et al.
Redox Biology (2024) Vol. 75, pp. 103261-103261
Open Access | Times Cited: 2
Targeting ferroptosis regulators in lung cancer: Exploring natural products
Yuhao Wang, Cheng Shenghua, Chen Jueying, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e33934-e33934
Open Access | Times Cited: 2
Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma
Yao Liang, Osamu Maeda, Chiaki Kondo, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307580-e0307580
Open Access | Times Cited: 2
Targeting NQO1 induces ferroptosis and triggers anti-tumor immunity in immunotherapy-resistant KEAP1-deficient cancers
Zhennan Yuan, Yuqin Wang, Boyu Qin, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101160-101160
Closed Access | Times Cited: 2
Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography
Hannah E. Greenwood, Abigail R. Barber, Richard Edwards, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Redox high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma
Xue‐Wu Wei, Chang Lu, Yichen Zhang, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top